Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P East

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 10, 2008
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZLloyd G Czaplewski, Ian Collins, E Andrew Boyd, et al.
Molecular Cancer Therapeutics|February 5, 2025
Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastomaSmita Matkar, Michael P East, Timothy J Stuhlmiller, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2026
Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancersMatthew D Sutcliffe, Kevin R Mott, Tulay Yilmaz-Swenson, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2008
Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivityMonika Ermann, Doris Riether, Edward R Walker, et al.
ACS Chemical Biology|July 25, 2022
Correction to "Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues"Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
ACS Chemical Biology|April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related AnaloguesPaul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthLinas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Journal of Medicinal Chemistry|February 16, 2019
SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)Christopher R M Asquith, Benedict-Tilman Berger, Jing Wan, et al.
Cancer Discovery|December 5, 2024
Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic ApproachesYi Xu, Xianlu L Peng, Michael P East, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activityStephen P East, Clara Bantry White, Oliver Barker, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|December 10, 2008
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZLloyd G Czaplewski, Ian Collins, E Andrew Boyd, et al.
Molecular Cancer Therapeutics|February 5, 2025
Kinome reprogramming of G2/M kinases and repression of MYCN contribute to superior efficacy of lorlatinib in ALK-driven neuroblastomaSmita Matkar, Michael P East, Timothy J Stuhlmiller, et al.
Biorxiv : the Preprint Server for Biology|March 16, 2026
Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancersMatthew D Sutcliffe, Kevin R Mott, Tulay Yilmaz-Swenson, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2008
Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivityMonika Ermann, Doris Riether, Edward R Walker, et al.
ACS Chemical Biology|July 25, 2022
Correction to "Mitochondrial Protease ClpP Is a Target for the Anticancer Compounds ONC201 and Related Analogues"Paul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
ACS Chemical Biology|April 26, 2019
Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related AnaloguesPaul R Graves, Lucas J Aponte-Collazo, Emily M J Fennell, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 10, 2018
Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell GrowthLinas J Krulikas, Ian M McDonald, Benjamin Lee, et al.
Journal of Medicinal Chemistry|February 16, 2019
SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)Christopher R M Asquith, Benedict-Tilman Berger, Jing Wan, et al.
Cancer Discovery|December 5, 2024
Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic ApproachesYi Xu, Xianlu L Peng, Michael P East, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activityStephen P East, Clara Bantry White, Oliver Barker, et al.
Pageof 9